Dr. Robin Deterding, MD
Pediatric Pulmonology (Pediatric Pulmonology Physician)
13123 E 16th Ave
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- Southern Illinois University School of Medicine (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
Licensed in Colorado since 1990, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: Southern Illinois University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Pulmonology Physician primary
CO license 30262 (first issued 1990; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University Physicians Incorporated (3,215 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 2 companies reported 7 payments worth $12,653 in total to this clinician.
| Boehringer Ingelheim International GmbH | $10,973 |
|---|---|
| Evoendo, Inc | $1,680 |
| Consulting Fee | $12,528 |
|---|---|
| Food and Beverage | $125 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim International GmbH Feb 15, 2025 | Consulting Fee OFEV · RESPIRATORY | $3,948 |
| Boehringer Ingelheim International GmbH Jan 9, 2025 | Consulting Fee OFEV · RESPIRATORY | $2,100 |
| Boehringer Ingelheim International GmbH Jun 1, 2025 | Consulting Fee | $2,100 |
| Boehringer Ingelheim International GmbH Apr 16, 2025 | Consulting Fee | $1,800 |
| Evoendo, Inc Mar 31, 2025 | Consulting Fee | $1,680 |
| Boehringer Ingelheim International GmbH Dec 10, 2025 | Consulting Fee | $900 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $353,414 in research payments for these studies, mostly to the institutions running them.
- An open-label trial of the long-term safety and tolerability of nintedanib per os, on top of standard of care, over at least 2 years, in children and adolescents with clinically significant fibrosing Interstitial Lung…
Boehringer Ingelheim Pharmaceuticals, Inc. - Pediatric ILD program
Boehringer Ingelheim Pharmaceuticals, Inc. - Pediatric Open-label extension study
Boehringer Ingelheim Pharma GmbH & Co.kg
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.